Local consolidative therapy extends survival in metastatic NSCLC with oligoresidual disease following first-line immunotherapy, irrespective of PD-L1 expression
局部巩固治疗可延长一线免疫治疗后残留病灶较少的转移性非小细胞肺癌患者的生存期,且与PD-L1表达无关。
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-20679-2
Xie, Wangti; Yan, Maohui; Wen, Fang; Wu, Yu; Cheng, Xiaosan; Hu, Jianbing; Xiao, Jia; Luo, Pan; Su, Yuqi; Ni, Ling; Shan, Rong; Yao, Xiang; Huang, Xianggan; Liu, Tunqian; Liu, Yuan; Weng, Jie